UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 25, 2007
BSD MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-10783 75-1590407
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification)
2188 West 2200 South
Salt Lake City, Utah 84119
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (801) 972-5555
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Item 7.01 Regulation FD Disclosure.
BSD Medical Corporation issued a press release on October 25, 2007. A copy
of the press release is hereby furnished as Exhibit 99.1 attached hereto.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release of BSD Medical Corporation dated October 25, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused October 25, 2007
By: /s/ Hyrum A. Mead
----------------------------------
President
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press Release of BSD Medical Corporation dated
October 25, 2007